Proficio Capital Partners’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-106
| Closed | -$9K | – | 1022 |
|
|
2019
Q2 | $9K | Buy |
106
+39
| +58% | +$3.31K | ﹤0.01% | 977 |
|
|
2019
Q1 | $6K | Buy |
67
+6
| +10% | +$537 | ﹤0.01% | 1061 |
|
|
2018
Q4 | $4K | Hold |
61
| – | – | ﹤0.01% | 903 |
|
|
2018
Q3 | $7K | Hold |
61
| – | – | ﹤0.01% | 887 |
|
|
2018
Q2 | $6K | Hold |
61
| – | – | ﹤0.01% | 952 |
|
|
2018
Q1 | $5K | Hold |
61
| – | – | ﹤0.01% | 1004 |
|
|
2017
Q4 | $5K | Buy |
61
+5
| +9% | +$410 | ﹤0.01% | 976 |
|
|
2017
Q3 | $3K | Hold |
56
| – | – | ﹤0.01% | 1036 |
|
|
2017
Q2 | $3K | Hold |
56
| – | – | ﹤0.01% | 1049 |
|
|
2017
Q1 | $3K | Buy |
+56
| New | +$3K | ﹤0.01% | 1082 |
|
|
2016
Q4 | – | Sell |
-11
| Closed | -$1K | – | 1163 |
|
|
2016
Q3 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 991 |
|